Evidence map›Paper›PMID 26568911›Full record

ArticleJournal of cancer policy2015

First International Workshopson Provocative Questions (PQ) in Cancer Research, October-November 2014, New Delhi, Bengaluru, and Thiruvananthapuram, India.

Preetha Rajaraman, Bindu Dey, Partha P Majumder, Satyajit Mayor, M Radhakrishna Pillai, S Ramaswamy, Chandrima Shaha, Maureen Johnson, Sudha Sivaram, Edward L Trimble and 2 more

Abstract read
In one paragraph

Article in Journal of cancer policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Preetha RajaramanCenter for Global Health, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, USA 20892.
Bindu DeyDepartment of Biotechnology (DBT), Government of India, New Delhi, India.
Partha P MajumderNational Institute of Biomedical Genomics, Netaji Subhas Sanatorium, 2nd Floor, P.O.: N.S.S., Kalyani 741251, West-Bengal, India.
Satyajit MayorInstitute for Stem Cell Biology and Regenerative Medicine (inSTEM) and National Centre for Biological Science (NCBS),Bellary Road, Bangalore 560065.
M Radhakrishna PillaiRajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, India.
S RamaswamyInstitute for Stem Cell Biology and Regenerative Medicine (inSTEM) and National Centre for Biological Science (NCBS),Bellary Road, Bangalore 560065.
Chandrima ShahaNational Institute of Immunology, ArunaAsaf Ali Marg New Delhi 110067, India.
Maureen JohnsonOffice of the Director, National Cancer Institute, NIH, DHHS, Bethesda, USA.
Sudha SivaramCenter for Global Health, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, USA 20892.
Edward L TrimbleCenter for Global Health, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, USA 20892.
Edward E HarlowOffice of the Director, National Cancer Institute, NIH, DHHS, Bethesda, USA.
K VijayRaghavanSecretary, Department of Biotechnology (DBT), Government of India, New Delhi, India.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

In 2011, the National Cancer Institute (NCI, USA) introduced the Provocative Questions (PQ) Initiative, a new approach allowing active researchers to define major unsolved or neglected problems in oncology unaddressed by existing funding. Last year, the U.S. NCI teamed up with the Indian Department of Biotechnology (DBT) to pilot the PQ approach in three cities in India. Workshop outcomes includedthe generation of fundable "PQs" (perplexing questions understudied by the international scientific community), as well as the identification of several non-PQ projects and research-related issues of importance to DBT and other Indian funding groups. The workshops clearly indicated the need to expand beyond crafting "PQs" when considering the best areas for research funding in international settings. Nonetheless, the first set of PQ workshops provided a forum to discuss key issues regarding cancer research in India, including the paucity of cancer research funding, and the lack of relevant human resource training and technology sharing platforms. Continued open debate between researchers, funders and policymakers will be essential to effectively strengthen the cancer research portfolio in India.

Indexed as

Cancer ResearchDepartment of BiotechnologyFundingIndiaNational Cancer InstituteProvocative Questions

Identifiers

PMID26568911
PMCPMC4642284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.